Literature DB >> 31734537

The more the merrier: how homo-oligomerization alters the interactome and function of ribonucleotide reductase.

Marcus J C Long1, Alexandra Van Hall-Beauvais2, Yimon Aye3.   

Abstract

Stereotyped as a nexus of dNTP synthesis, the dual-subunit enzyme - ribonucleotide reductase (RNR) - is coming into view as a paradigm of oligomerization and moonlighting behavior. In the present issue of 'omics', we discuss what makes the larger subunit of this enzyme (RNR-α) so interesting, highlighting its emerging cellular interactome based on its unique oligomeric dynamism that dictates its compartment-specific occupations. Linking the history of the field with the multivariable nature of this exceedingly sophisticated enzyme, we further discuss implications of new data pertaining to DNA-damage response, S-phase checkpoints, and ultimately tumor suppression. We hereby hope to provide ideas for those interested in these fields and exemplify conceptual frameworks and tools that are useful to study RNR's broader roles in biology.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Chemotherapeutics; DNA damage; Moonlighting; Protein-protein associations; Tumor suppression; ZRANB3

Mesh:

Substances:

Year:  2019        PMID: 31734537      PMCID: PMC7131891          DOI: 10.1016/j.cbpa.2019.09.003

Source DB:  PubMed          Journal:  Curr Opin Chem Biol        ISSN: 1367-5931            Impact factor:   8.822


  37 in total

Review 1.  Extracellular ATP as a signaling molecule for epithelial cells.

Authors:  Erik M Schwiebert; Akos Zsembery
Journal:  Biochim Biophys Acta       Date:  2003-09-02

Review 2.  Ribonucleotide reductases: radical enzymes with suicidal tendencies.

Authors:  J Stubbe; W A van der Donk
Journal:  Chem Biol       Date:  1995-12

3.  Nuclear RNR-α antagonizes cell proliferation by directly inhibiting ZRANB3.

Authors:  Yuan Fu; Marcus J C Long; Somsinee Wisitpitthaya; Huma Inayat; Timothy M Pierpont; Islam M Elsaid; Jordana C Bloom; Joaquin Ortega; Robert S Weiss; Yimon Aye
Journal:  Nat Chem Biol       Date:  2018-08-27       Impact factor: 15.040

4.  Mrc1 and Rad9 cooperate to regulate initiation and elongation of DNA replication in response to DNA damage.

Authors:  Julien Bacal; María Moriel-Carretero; Benjamin Pardo; Antoine Barthe; Sushma Sharma; Andrei Chabes; Armelle Lengronne; Philippe Pasero
Journal:  EMBO J       Date:  2018-08-29       Impact factor: 11.598

Review 5.  Discovery and development of clofarabine: a nucleoside analogue for treating cancer.

Authors:  Peter L Bonate; Larry Arthaud; William R Cantrell; Katherine Stephenson; John A Secrist; Steve Weitman
Journal:  Nat Rev Drug Discov       Date:  2006-10       Impact factor: 84.694

Review 6.  Functions of SMARCAL1, ZRANB3, and HLTF in maintaining genome stability.

Authors:  Lisa A Poole; David Cortez
Journal:  Crit Rev Biochem Mol Biol       Date:  2017-09-28       Impact factor: 8.250

7.  Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes.

Authors:  H Land; L F Parada; R A Weinberg
Journal:  Nature       Date:  1983 Aug 18-24       Impact factor: 49.962

8.  Enzyme regulation. IRBIT is a novel regulator of ribonucleotide reductase in higher eukaryotes.

Authors:  Alexei Arnaoutov; Mary Dasso
Journal:  Science       Date:  2014-09-19       Impact factor: 47.728

9.  Smarcal1 and Zranb3 Protect Replication Forks from Myc-Induced DNA Replication Stress.

Authors:  Matthew V Puccetti; Clare M Adams; Saul Kushinsky; Christine M Eischen
Journal:  Cancer Res       Date:  2019-01-04       Impact factor: 12.701

10.  Reversible, long-range radical transfer in E. coli class Ia ribonucleotide reductase.

Authors:  Ellen C Minnihan; Daniel G Nocera; Joanne Stubbe
Journal:  Acc Chem Res       Date:  2013-06-04       Impact factor: 22.384

View more
  4 in total

Review 1.  Ribonucleotide Reductases: Structure, Chemistry, and Metabolism Suggest New Therapeutic Targets.

Authors:  Brandon L Greene; Gyunghoon Kang; Chang Cui; Marina Bennati; Daniel G Nocera; Catherine L Drennan; JoAnne Stubbe
Journal:  Annu Rev Biochem       Date:  2020-06-20       Impact factor: 23.643

Review 2.  Science's Response to CoVID-19.

Authors:  Marcus J C Long; Yimon Aye
Journal:  ChemMedChem       Date:  2021-06-22       Impact factor: 3.540

3.  Cryo-EM structure of the EBV ribonucleotide reductase BORF2 and mechanism of APOBEC3B inhibition.

Authors:  Nadine M Shaban; Rui Yan; Ke Shi; Sofia N Moraes; Adam Z Cheng; Michael A Carpenter; Jason S McLellan; Zhiheng Yu; Reuben S Harris
Journal:  Sci Adv       Date:  2022-04-27       Impact factor: 14.957

Review 4.  Wrangling Shape-Shifting Morpheeins to Tackle Disease and Approach Drug Discovery.

Authors:  Eileen K Jaffe
Journal:  Front Mol Biosci       Date:  2020-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.